Rivus Pharmaceuticals Launches with $35 Million Series A Financing to Develop Novel Treatments for Cardio-Metabolic Diseases

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/2UqAMBk
via IFTTT